[
  {
    "ts": null,
    "headline": "Pfizer Q4 Earnings Preview: 5 Critical Business Issues To Consider",
    "summary": "Financial analysis of Pfizer Inc. stock ahead of its earnings release. PFE faces significant headwinds from patent expiries, click for my updated look at the stock.",
    "url": "https://finnhub.io/api/news?id=635f70ede4cab57879dcdf69cd9a4237560cc58ffe2efc18c6c2479b43622855",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738077110,
      "headline": "Pfizer Q4 Earnings Preview: 5 Critical Business Issues To Consider",
      "id": 132487797,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1491484031/image_1491484031.jpg?io=getty-c-w1536",
      "related": "LLY",
      "source": "SeekingAlpha",
      "summary": "Financial analysis of Pfizer Inc. stock ahead of its earnings release. PFE faces significant headwinds from patent expiries, click for my updated look at the stock.",
      "url": "https://finnhub.io/api/news?id=635f70ede4cab57879dcdf69cd9a4237560cc58ffe2efc18c6c2479b43622855"
    }
  },
  {
    "ts": null,
    "headline": "Drugmakers Show Restraint on Price Increases in New Trump Era",
    "summary": "Drugmakers Show Restraint on Price Increases in New Trump Era",
    "url": "https://finnhub.io/api/news?id=f17a76ce54722d42e46d57502373ff6b6b7457c0b31bbeec482cfbcfe634f5e6",
    "source": "DowJones",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738076400,
      "headline": "Drugmakers Show Restraint on Price Increases in New Trump Era",
      "id": 132521086,
      "image": "",
      "related": "LLY",
      "source": "DowJones",
      "summary": "Drugmakers Show Restraint on Price Increases in New Trump Era",
      "url": "https://finnhub.io/api/news?id=f17a76ce54722d42e46d57502373ff6b6b7457c0b31bbeec482cfbcfe634f5e6"
    }
  },
  {
    "ts": null,
    "headline": "NIE: Quarterly Update On An Excellent Equity And Convertible Fund",
    "summary": "The Virtus Equity & Convertible Income Fund is attracting income-focused investors with its high yield and strong performance. Learn more on NIE CEF here.",
    "url": "https://finnhub.io/api/news?id=21aa62cc6ab5b6962c2285c0e5e217ade81764360204e7beaa6dd32c64cffebd",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738062021,
      "headline": "NIE: Quarterly Update On An Excellent Equity And Convertible Fund",
      "id": 132486654,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/120915748/image_120915748.jpg?io=getty-c-w1536",
      "related": "LLY",
      "source": "SeekingAlpha",
      "summary": "The Virtus Equity & Convertible Income Fund is attracting income-focused investors with its high yield and strong performance. Learn more on NIE CEF here.",
      "url": "https://finnhub.io/api/news?id=21aa62cc6ab5b6962c2285c0e5e217ade81764360204e7beaa6dd32c64cffebd"
    }
  }
]